Mäkinen, L.; Vähä-Koskela, M.; Juusola, M.; Mustonen, H.; Wennerberg, K.; Hagström, J.; Puolakkainen, P.; Seppänen, H.
Pancreatic Cancer Organoids in the Field of Precision Medicine: A Review of Literature and Experience on Drug Sensitivity Testing with Multiple Readouts and Synergy Scoring. Cancers 2022, 14, 525.
https://doi.org/10.3390/cancers14030525
AMA Style
Mäkinen L, Vähä-Koskela M, Juusola M, Mustonen H, Wennerberg K, Hagström J, Puolakkainen P, Seppänen H.
Pancreatic Cancer Organoids in the Field of Precision Medicine: A Review of Literature and Experience on Drug Sensitivity Testing with Multiple Readouts and Synergy Scoring. Cancers. 2022; 14(3):525.
https://doi.org/10.3390/cancers14030525
Chicago/Turabian Style
Mäkinen, Lotta, Markus Vähä-Koskela, Matilda Juusola, Harri Mustonen, Krister Wennerberg, Jaana Hagström, Pauli Puolakkainen, and Hanna Seppänen.
2022. "Pancreatic Cancer Organoids in the Field of Precision Medicine: A Review of Literature and Experience on Drug Sensitivity Testing with Multiple Readouts and Synergy Scoring" Cancers 14, no. 3: 525.
https://doi.org/10.3390/cancers14030525
APA Style
Mäkinen, L., Vähä-Koskela, M., Juusola, M., Mustonen, H., Wennerberg, K., Hagström, J., Puolakkainen, P., & Seppänen, H.
(2022). Pancreatic Cancer Organoids in the Field of Precision Medicine: A Review of Literature and Experience on Drug Sensitivity Testing with Multiple Readouts and Synergy Scoring. Cancers, 14(3), 525.
https://doi.org/10.3390/cancers14030525